Viktor KuncakViktor Kunčak joined EPFL in 2007, after receiving a PhD degree from MIT. Since then has been leading the Laboratory for Automated Reasoning and Analysis and supervised at least 12 completed PhD theses. His works on languages, algorithms and systems for verification and automated reasoning. He served as an initiator and one of the coordinators of a European network (COST action) in the area of automated reasoning, verification, and synthesis. In 2012 he received a 5-year single-investigator European Research Council (ERC) grant of 1.5M EUR. His invited talks include those at Lambda Days, Scala Days, NFM, LOPSTR, SYNT, ICALP, CSL, RV, VMCAI, and SMT. A paper on test generation he co-authored received an ACM SIGSOFT distinguished paper award at ICSE. A PLDI paper he co-authored was published in the Communications of the ACM as a Research Highlight article. His Google Scholar profile reports an over-approximate H-index of 38. He was an associate editor of ACM Transactions on Programming Languages and Systems (TOPLAS) and served as a co-chair of conferences on Computer-Aided Verification (CAV), Formal Methods in Computer Aided Design (FMCAD), Workshop on Synthesis (SYNT), and Verification, Model Checking, and Abstract Interpretation (VMCAI). At EPFL he teaches courses on functional and parallel programming, compilers, and verification. He has co-taught the MOOC "Parallel Programming" that was visited by over 100'000 learners and completed by thousands of students from all over the world.
Caroline VandevyverCaroline Vandevyver received her degree in biochemistry in 1985 from the Katholieke Universiteit Leuven, Belgium and her Ph.D. degree in biotechnology at the same university in 1989.
She joined the Biomedical Research Institute "Dr. L- Willems Instituut" in Hasselt, Belgium, in 1989. Subsequently, she has worked there on T cell mediated autoimmune diseases (Multiple Sclerosis, Rheumatoid Arthritis), genetic association and linkage studies in multifactorial diseases, mutation analysis of genetic disorders (Phenylketonuria, alpha 1 anti-trypsine deficiency, congenital adrenal hyperplasia) and the development of active and passive immune therapies for cancer.
She joined EPFL in 2000 at the Laboratory of Chemical Biotechnology headed by Prof. Ruth Freitag, where she was responsible for the cell culture lab and the (recombinant) protein purification and characterization. She joined the Laboratory of Lanthanide Supramolecular Chemistry (LCSL) in May 2006, where she was responsible for the live cell imaging project with Lanthanide complexes.
In 2005, she joined the Office of the Research Commission. Her duties there were the management of national and international fellowship programs, the management of local research awards and the promotion of research performed at EPFL. In August 2013, she was nominated coordinator of the International Funding, one of the pillars of the Research Office at EPFL. Since January 2017, she is the Head of EPFL's Research Office.
